Search results
Results From The WOW.Com Content Network
Major investors say AstraZeneca boss is ‘massively underpaid’ on $21.5 million salary, despite earning more than double Novo Nordisk’s CEO ... ($11.9 million) pay package. A year later, 35% ...
In 2023, Soriot was the highest paid CEO of the major European pharmaceutical companies, as he earned $21.3 million. That was a nearly 12 per cent increase over 2022. [16] In March 2024, Soriot was awarded the President's Medal by the Society of Chemical Industry for leading AstraZeneca’s COVID-19 vaccination programme. [17]
On 19 May 2014, AstraZeneca rejected a "final offer" from Pfizer of £55 per share, which valued the company at £69.4 billion (US$117 billion). The companies had been meeting since January 2014. The companies had been meeting since January 2014.
Richardson's salary was criticised as excessive in 2017 (quoted as £410,000). [92] Richardson was separately criticized for abuse of expenses, including claiming £70,000 in a single year on travel and dining as vice-chancellor. [93] Richardson publicly lists her expenses on the university website. [94]
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.
(Reuters) -AstraZeneca said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 per month in the United States, starting June, following a similar move by rival ...
Sir Adrian Vivian Sinton Hill, KBE FRS FMedSci FRCP (born 9 October 1958) [2] is a British-Irish vaccinologist who is Director of the Jenner Institute and Lakshmi Mittal and Family Professor of Vaccinology at the University of Oxford, an honorary Consultant Physician in Infectious Diseases, [3] and Fellow of Magdalen College, Oxford. [4]
Alexion Pharmaceuticals was founded in 1992 at Science Park in New Haven, Connecticut by Steven Squinto and Leonard Bell, a physician at Yale New Haven Hospital and assistant professor of medicine and pathology at Yale School of Medicine.